We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
This analysis discusses the potential benefits of long-acting injectable antipsychotics in bipolar I disorder, particularly in cases with manic predominance.
No takes yet. Share an insight, caveat, or question.
Cavaleri et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: